Showing 1 - 10 of 348
Persistent link: https://www.econbiz.de/10004967989
Under Medicare Part D, senior citizens choose prescription drug insurance offred by numerous private insurers. We examine non-poor enrollees' actions in 2006 and 2007 using panel data. Our sample reduced overspending by $298 on average, with gains by 81% of them. The greatest improvements were...
Persistent link: https://www.econbiz.de/10009322981
In the case of natural monopolies there tends to be a trade-off between a higher quality of output provided by private firms, and a better access for poor consumers provided by public firms. This is partly the reflection of differences in objectives by private and public firms. The former tend...
Persistent link: https://www.econbiz.de/10009643502
Patient mobility is a key issue in the EU who recently passed a new law on patients' right to EU-wide provider choice. In this paper we use a Hotelling model with two regions that differ in technology to study the impact of patient mobility on health care quality, health care financing and...
Persistent link: https://www.econbiz.de/10009293984
Persistent link: https://www.econbiz.de/10010752112
This paper aims to assess the effect of the APA on the care received by disabled elderly people living in the community. Using data from the French Handicap Santé Ménage Survey, we propose an empirical analysis using the propensity score matching method. Our results suggest that the use of...
Persistent link: https://www.econbiz.de/10010706514
Persistent link: https://www.econbiz.de/10010706625
Hospital heterogeneity is a major issue in defining a reimbursement system. If hospitals are heterogeneous, it is difficult to distinguish which part of the differences in costs is due to cost containment efforts and which part cannot be reduced, because it is due to other unobserved sources of...
Persistent link: https://www.econbiz.de/10010706753
BACKGROUND: In 2005, the French Government implemented a new way of financing high-cost drugs for hospitals in order to promote innovation. Such drugs are gathered on a positive list, established by the Ministry of Health, with a reimbursement price cap. Hospitals still negotiate with...
Persistent link: https://www.econbiz.de/10010706947
B. Dormont entend combattre l'idée selon laquelle les dépenses de santé vont croître du fait du vieillissement de la population. L'augmentation serait due, d'après elle, aux changements de pratiques dans la consommation des soins, laquelle tient en partie aux innovations médicales, ce qui...
Persistent link: https://www.econbiz.de/10010707337